A detailed history of Champlain Investment Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 3,080,703 shares of EW stock, worth $209 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares
3,080,703
Previous 2,948,188 4.49%
Holding current value
$209 Million
Previous $272 Million 25.35%
% of portfolio
1.29%
Previous 1.73%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$59.7 - $93.78 $7.91 Million - $12.4 Million
132,515 Added 4.49%
3,080,703 $203 Million
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $1.35 Million - $1.51 Million
-15,980 Reduced 0.54%
2,948,188 $272 Million
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $6.4 Million - $8.43 Million
88,205 Added 3.07%
2,964,168 $283 Million
Q4 2023

Feb 13, 2024

BUY
$61.71 - $77.76 $6.7 Million - $8.45 Million
108,640 Added 3.93%
2,875,963 $219 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $219,617 - $296,014
-3,170 Reduced 0.11%
2,767,323 $192 Million
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $556,844 - $645,217
6,840 Added 0.25%
2,770,493 $261 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $14 Million - $16 Million
-189,150 Reduced 6.41%
2,763,653 $229 Million
Q4 2022

Feb 13, 2023

SELL
$68.3 - $87.44 $2.2 Million - $2.82 Million
-32,213 Reduced 1.08%
2,952,803 $220 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $5.27 Million - $6.86 Million
-63,930 Reduced 2.1%
2,985,016 $247 Million
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $3.12 Million - $4.63 Million
-36,111 Reduced 1.17%
3,048,946 $290 Million
Q1 2022

May 12, 2022

BUY
$101.96 - $128.34 $3.22 Million - $4.05 Million
31,560 Added 1.03%
3,085,057 $363 Million
Q4 2021

Feb 10, 2022

SELL
$106.37 - $130.68 $1.78 Million - $2.19 Million
-16,775 Reduced 0.55%
3,053,497 $396 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $11.2 Million - $13.4 Million
-108,855 Reduced 3.42%
3,070,272 $348 Million
Q2 2021

Aug 12, 2021

SELL
$83.84 - $104.76 $1.35 Million - $1.68 Million
-16,080 Reduced 0.5%
3,179,127 $329 Million
Q1 2021

May 13, 2021

BUY
$78.68 - $90.67 $29.2 Million - $33.7 Million
371,210 Added 13.14%
3,195,207 $267 Million
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $3.74 Million - $4.76 Million
-52,145 Reduced 1.81%
2,823,997 $258 Million
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $1.74 Million - $2.26 Million
25,860 Added 0.91%
2,876,142 $230 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $110 Million - $147 Million
1,913,728 Added 204.34%
2,850,282 $197 Million
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $1.5 Million - $2.32 Million
28,654 Added 3.16%
936,554 $177 Million
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $274,611 - $314,404
3,830 Added 0.42%
907,900 $212 Million
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $4.98 Million - $6.1 Million
80,835 Added 9.82%
904,070 $199 Million
Q2 2019

Aug 13, 2019

BUY
$55.74 - $64.41 $5.31 Million - $6.14 Million
95,335 Added 13.1%
823,235 $152 Million
Q1 2019

May 14, 2019

BUY
$47.89 - $64.05 $2.75 Million - $3.68 Million
57,390 Added 8.56%
727,900 $139 Million
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $535,803 - $657,372
11,545 Added 1.75%
670,510 $103 Million
Q3 2018

Nov 13, 2018

BUY
$45.7 - $58.03 $1 Million - $1.28 Million
21,975 Added 3.45%
658,965 $115 Million
Q2 2018

Aug 13, 2018

BUY
$42.45 - $51.3 $3.1 Million - $3.74 Million
72,965 Added 12.94%
636,990 $92.7 Million
Q1 2018

May 14, 2018

BUY
$37.19 - $47.45 $2.37 Million - $3.02 Million
63,685 Added 12.73%
564,025 $78.7 Million
Q4 2017

Feb 12, 2018

BUY
$33.79 - $39.39 $16.9 Million - $19.7 Million
500,340
500,340 $56.4 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Champlain Investment Partners, LLC Portfolio

Follow Champlain Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.